Published in Cochrane Database Syst Rev on January 01, 2004
Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev (2009) 4.47
Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev (2013) 2.33
The effectiveness of interventions to change six health behaviours: a review of reviews. BMC Public Health (2010) 1.79
Engaging physicians and pharmacists in providing smoking cessation counseling. Arch Intern Med (2010) 1.59
How to promote healthy behaviours in patients? An overview of evidence for behaviour change techniques. Health Promot Int (2010) 1.39
Internet-based photoaging within Australian pharmacies to promote smoking cessation: randomized controlled trial. J Med Internet Res (2013) 1.16
Ask, advise and refer: hypothesis generation to promote a brief tobacco-cessation intervention in community pharmacies. Int J Pharm Pract (2009) 0.94
Community pharmacists' experiences in mental illness and addictions care: a qualitative study. Subst Abuse Treat Prev Policy (2016) 0.93
A tailored intervention to support pharmacy-based counseling for smoking cessation. Nicotine Tob Res (2010) 0.93
The roles of community pharmacists in cardiovascular disease prevention and management. Australas Med J (2011) 0.88
A workshop on smoking cessation for pharmacy students. Am J Pharm Educ (2013) 0.86
The role of academic pharmacy in tobacco cessation and control. Am J Pharm Educ (2013) 0.83
Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study. BMC Health Serv Res (2010) 0.83
Community pharmacy interventions for public health priorities: protocol for a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions. Syst Rev (2014) 0.81
Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial. Trials (2015) 0.80
Assessing healthcare providers' knowledge and practices relating to insecticide-treated nets and the prevention of malaria in Ghana, Laos, Senegal and Tanzania. Malar J (2011) 0.80
The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review. Pharm Pract (Granada) (2013) 0.80
Initial uptake of the Ontario Pharmacy Smoking Cessation Program: Descriptive analysis over 2 years. Can Pharm J (Ott) (2015) 0.79
Smoking cessation in community pharmacy practice-a clinical information needs analysis. Springerplus (2013) 0.78
Community pharmacists' involvement in smoking cessation: familiarity and implementation of the National smoking cessation guideline in Finland. BMC Public Health (2010) 0.78
The role of pharmacists in smoking cessation in Poland. Eval Health Prof (2009) 0.77
Surveying the Knowledge and Practices of Health Professionals in China, India, Iran, and Mexico on Treating Tuberculosis. Am J Trop Med Hyg (2016) 0.76
Smoking treatment optimisation in pharmacies (STOP): a cluster randomised pilot trial of a training intervention. Pilot Feasibility Stud (2017) 0.75
An introduction to the fundamentals of randomized controlled trials in pharmacy research. Can J Hosp Pharm (2015) 0.75
Identifying effective behavioural components of Intervention and Comparison group support provided in SMOKing cEssation (IC-SMOKE) interventions: a systematic review protocol. Syst Rev (2016) 0.75
Optimizing identification and management of COPD patients - reviewing the role of the community pharmacist. Br J Clin Pharmacol (2016) 0.75
A Smoke-Free Paso del Norte: impact over 10 years on smoking prevalence using the Behavioral Risk Factor Surveillance System. Am J Public Health (2011) 0.75
Pharmaceutical care in smoking cessation. Patient Prefer Adherence (2015) 0.75
What works for whom in pharmacist-led smoking cessation support: realist review. BMC Med (2016) 0.75
Clinicians' knowledge and practices regarding family planning and intrauterine devices in China, Kazakhstan, Laos and Mexico. Reprod Health (2016) 0.75
Community Pharmacists' Involvement in Research in the United Kingdom. Pharmacy (Basel) (2017) 0.75
A community pharmacy-based cardiovascular risk screening service implemented in Iran. Pharm Pract (Granada) (2017) 0.75
Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev (2005) 4.86
Antidepressants for smoking cessation. Cochrane Database Syst Rev (2007) 4.62
Self-help interventions for smoking cessation. Cochrane Database Syst Rev (2005) 4.27
Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev (2007) 3.30
Change in the established prescribing habits of general practitioners: an analysis of initial prescriptions in general practice. Br J Gen Pract (1991) 2.89
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess (2011) 2.71
Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev (2007) 2.27
Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours. Cochrane Database Syst Rev (2003) 2.22
Nursing interventions for smoking cessation. Cochrane Database Syst Rev (2008) 2.04
Limited list: limited effects? Br Med J (Clin Res Ed) (1985) 1.93
Clonidine for smoking cessation. Cochrane Database Syst Rev (2004) 1.80
Self-help interventions for smoking cessation. Cochrane Database Syst Rev (2002) 1.63
Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev (2007) 1.59
Hormone replacement therapy: a study of women's knowledge and attitudes. Br J Gen Pract (1993) 1.53
General practice management of illicit drug users in Scotland: a national survey. Addiction (2003) 1.52
Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev (2001) 1.48
The effect of folic acid supplementation on plasma homocysteine in an elderly population. QJM (2002) 1.44
Physician advice for smoking cessation. Cochrane Database Syst Rev (2001) 1.39
Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: a randomised controlled trial in Scotland. Tob Control (1998) 1.39
Hypnotherapy for smoking cessation. Cochrane Database Syst Rev (2000) 1.39
Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev (2003) 1.39
Nursing interventions for smoking cessation. Cochrane Database Syst Rev (2001) 1.32
Educational strategies to promote evidence-based community pharmacy practice: a cluster randomized controlled trial (RCT). Fam Pract (2002) 1.31
Nursing interventions for smoking cessation. Cochrane Database Syst Rev (2004) 1.30
Antidepressants for smoking cessation. Cochrane Database Syst Rev (2003) 1.30
Attitudinal factors associated with community pharmacists' involvement in services for drug misusers. Addiction (1999) 1.25
Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. BMJ (2001) 1.18
Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting. Qual Saf Health Care (2006) 1.17
Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev (2000) 1.15
Antidepressants for smoking cessation. Cochrane Database Syst Rev (2000) 1.12
Self-help interventions for smoking cessation. Cochrane Database Syst Rev (2000) 1.11
The cost of medicines in the United Kingdom. A survey of general practitioners' opinions and knowledge. Pharmacoeconomics (1997) 1.09
Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev (2002) 1.04
Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev (2005) 0.99
Opioid antagonists for smoking cessation. Cochrane Database Syst Rev (2006) 0.99
Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev (2004) 0.96
Pharmacovigilance of over-the-counter products based in community pharmacy: a feasible option? Pharmacoepidemiol Drug Saf (1999) 0.92
Mecamylamine (a nicotine antagonist) for smoking cessation. Cochrane Database Syst Rev (2000) 0.92
Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? Addiction (2002) 0.89
Anxiolytics for smoking cessation. Cochrane Database Syst Rev (2000) 0.88
Pharmacovigilance of over-the-counter products based in community pharmacy: methodological issues from pilot work conducted in Hampshire and Grampian, UK. Pharmacoepidemiol Drug Saf (2002) 0.87
Community pharmacists' views and beliefs about the treatment of symptoms suggestive of vaginal thrush in community pharmacies. Pharm World Sci (2000) 0.87
Anxiolytics and antidepressants for smoking cessation. Cochrane Database Syst Rev (2000) 0.86
Women's knowledge of and attitudes towards hormone replacement therapy. Fam Pract (2003) 0.86
Aversive smoking for smoking cessation. Cochrane Database Syst Rev (2004) 0.85
Nursing interventions for smoking cessation. Cochrane Database Syst Rev (2000) 0.85
Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev (2001) 0.84
Opioid antagonists for smoking cessation. Cochrane Database Syst Rev (2001) 0.84
Antidepressants for smoking cessation. Cochrane Database Syst Rev (2002) 0.83
Aversive smoking for smoking cessation. Cochrane Database Syst Rev (2000) 0.82
Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies: some methodological issues. Drug Saf (2001) 0.82
Independent nursing practice: a national survey of attitudes of practice employed nurses in Scotland. Health Bull (Edinb) (2001) 0.81
Clonidine for smoking cessation. Cochrane Database Syst Rev (2000) 0.80
Using human error theory to explore the supply of non-prescription medicines from community pharmacies. Qual Saf Health Care (2006) 0.79
A pharmaceutical needs assessment in a primary care setting. Br J Gen Pract (2000) 0.79
Silver acetate for smoking cessation. Cochrane Database Syst Rev (2000) 0.79
Photolytic decomposition of 3 cobalamins: a quantitative study. J Pharm Pharmacol (1972) 0.78
Prescribing and dispensing for drug misusers in primary care: current practice in Scotland. Fam Pract (1999) 0.77
Coenzyme B 12 : correlation of ultraviolet, electrophoretic and enzyme assay methods. J Pharm Pharmacol (1972) 0.75
Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev (2001) 0.75
Specialist drug misuse nurse's motivation, clinical decision-making and professional communication: an exploratory study. J Psychiatr Ment Health Nurs (2004) 0.75
Over-the-counter emergency contraception: a feasible option. Fam Pract (1998) 0.75